Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Raw Materials (2016)

Rockwell Medical filings provide 6 years of Raw Materials readings, the most recent being $8.6 million for Q3 2016.

  • On a quarterly basis, Raw Materials rose 68.47% to $8.6 million in Q3 2016 year-over-year; TTM through Sep 2016 was $8.6 million, a 68.47% increase, with the full-year FY2015 number at $5.5 million, up 150.55% from a year prior.
  • Raw Materials hit $8.6 million in Q3 2016 for Rockwell Medical, up from $8.1 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $8.6 million in Q3 2016 to a low of $1.0 million in Q4 2012.
  • Median Raw Materials over the past 5 years was $1.8 million (2014), compared with a mean of $3.4 million.
  • Biggest five-year swings in Raw Materials: dropped 2.33% in 2014 and later soared 273.66% in 2015.
  • Rockwell Medical's Raw Materials stood at $1.0 million in 2012, then rose by 12.19% to $1.1 million in 2013, then soared by 92.26% to $2.2 million in 2014, then soared by 150.55% to $5.5 million in 2015, then surged by 56.61% to $8.6 million in 2016.
  • The last three reported values for Raw Materials were $8.6 million (Q3 2016), $8.1 million (Q2 2016), and $6.7 million (Q1 2016) per Business Quant data.